Related Experiment Video

Updated: Mar 2, 2026

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.3K

Current recommendations for community-acquired pneumonia

A L Esposito1

  • 1Saint Vincent Hospital, Worcester, Massachusetts, USA.

Contemporary Internal Medicine
|January 8, 1995
PubMed

Insights

Choosing the right antimicrobial drugs is difficult due to vague symptoms and imperfect diagnostic tests. This study examines empiric therapy and outlines management strategies for treatment failure.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Pharmacology

Background:

  • Antimicrobial selection is challenging due to nonspecific clinical signs and symptoms.
  • Diagnostic tests for infections have inherent limitations, impacting treatment decisions.
  • Empiric antimicrobial therapy is frequently necessary in clinical practice.

Purpose of the Study:

  • To explore the role and challenges of empiric antimicrobial therapy.
  • To provide guidance on managing cases where initial empiric treatment fails.
  • To improve clinical decision-making in antimicrobial prescribing.

Main Methods:

  • Review of current literature on empiric antimicrobial therapy.
  • Analysis of factors influencing the choice of empiric agents.
  • Development of a framework for managing treatment failures.

Main Results:

  • Imprecise clinical presentation and diagnostic limitations necessitate empiric therapy.
  • Failure of empiric therapy requires a systematic approach to reassess diagnosis and treatment.
  • Alternative antimicrobial agents and diagnostic strategies are crucial for refractory infections.

Conclusions:

  • Optimizing empiric antimicrobial therapy requires careful consideration of local resistance patterns and patient factors.
  • A structured approach to treatment failure is essential for effective patient outcomes.
  • Further research into rapid diagnostics and novel antimicrobial agents is warranted.

More Related Videos

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia13:27

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Published on: May 6, 2014

49.2K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
538
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.7K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
903
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.1K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.6K